Reducing Heart Dose with Protons and Cardiac Substructure Sparing for Mediastinal Lymphoma Treatment

Kekoa Taparra1,2,3, Scott C Lester1, W Scott Harmsen4,3

  • 1Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.

Summary

Intensity modulated proton therapy (IMPT) significantly reduces radiation dose to the heart and lungs in patients with mediastinal lymphoma compared to intensity modulated radiation therapy (IMRT). This cardiac substructure sparing (CSS) optimization may lead to improved clinical outcomes.